ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA grants Orphan Drug Designation for etoposide toniribate americanpharmaceuticalreview
February 26, 2019Mundipharma EDO GmbH and Imbrium Therapeutics announced the US FDA has granted Orphan Drug Designation (ODD) to etoposide toniribate for the treatment of relapsed/refractory biliary tract cancer, also known as cholangiocarcinoma.
Pharma Sources Insight January 2025
